Aardvark Therapeutics, Inc. (AARD) Discusses Efficacy and Safety Data From Terminated HERO Phase III and Open-Label Extension Trials TranscriptSeeking Alpha · 3 days ago
Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension TrialsGlobeNewsWire · 4 days ago
106,976 Global X Video Games & Esports ETF $HERO Shares Bought by Envestnet Asset Management Inc.Defense World · Oct 5, 2026
AARD DEADLINE NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026GuruFocus · Sep 28, 2026
AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Fraud Class ActionGuruFocus · Sep 21, 2026
Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff DeadlineGuruFocus · Sep 7, 2026HERO provides access to companies whose principal business have or are expected have significant exposure to the field of video games and esports. An algorithm screens company filings for keywords that match the index theme to identify and rank companies. Eligible securities meeting minimum market-cap and liquidity requirements must also generate at least 50% of its revenues from video games or esports activities to be selected for index inclusion.